Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson’s disease

Objective Severe hyposmia is a risk factor of dementia in Parkinson’s disease (PD), while the underlying functional connectivity (FC) and brain volume alterations in PD patients with severe hyposmia (PD-SH) are unclear. Methods We examined voxel-based morphometric and resting state functional magnetic resonance imaging findings in 15 cognitively normal PD-SH, 15 cognitively normal patients with PD with no/mild hyposmia (PD-N/MH), and 15 healthy controls (HCs). Results Decreased gray matter volume (GMV) was observed in the bilateral cuneus, right associative visual area, precuneus, and some areas in anterior temporal lobes in PD-SH group compared to HCs. Both the PD-SH and PD-N/MH groups showed increased GMV in the bilateral posterior insula and its surrounding regions. A widespread significant decrease in amygdala FC beyond the decreased GMV areas and olfactory cortices were found in the PD-SH group compared with the HCs. Above all, decreased amygdala FC with the inferior parietal lobule, lingual gyrus, and fusiform gyrus was significantly correlated with both reduction of Addenbrooke’s Cognitive Examination-Revised scores and severity of hyposmia in all participants. Canonical resting state networks exhibited decreased FC in the precuneus and left executive control networks but increased FC in the primary and high visual networks of patients with PD compared with HCs. Canonical network FC to other brain regions was enhanced in the executive control, salience, primary visual, and visuospatial networks of the PD-SH. Conclusion PD-SH showed extensive decreased amygdala FC. Particularly, decreased FC between the amygdala and inferior parietal lobule, lingual gyrus, and fusiform gyrus were associated with the severity of hyposmia and cognitive performance. In contrast, relatively preserved canonical networks in combination with increased FC to brain regions outside of canonical networks may be related to compensatory mechanisms, and preservation of brain function.

[1]  P. Matthews,et al.  Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.

[2]  G. Vingerhoets,et al.  Cognitive Differences Between Patients with Left-sided and Right-sided Parkinson’s Disease. A Review , 2011, Neuropsychology Review.

[3]  S. Rombouts,et al.  Resting-state functional MR imaging: a new window to the brain. , 2014, Radiology.

[4]  Nadja Deris,et al.  Functional connectivity in the resting brain as biological correlate of the Affective Neuroscience Personality Scales , 2017, NeuroImage.

[5]  G. Rees,et al.  Measuring compensation in neurodegeneration using MRI , 2017, Current opinion in neurology.

[6]  John R Hodges,et al.  The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening , 2006, International journal of geriatric psychiatry.

[7]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[8]  R. Doty.  Olfaction in Parkinson's disease. , 2007, Parkinsonism & related disorders.

[9]  Barbara Cerf-Ducastel,et al.  Neural substrates of cross-modal olfactory recognition memory: An fMRI study , 2006, NeuroImage.

[10]  R. Barker,et al.  Addenbrooke's Cognitive Examination‐Revised for mild cognitive impairment in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[11]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[12]  L. Moran,et al.  Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[13]  D. Waldvogel,et al.  Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression , 2014, Movement disorders : official journal of the Movement Disorder Society.

[14]  G. Halliday,et al.  Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.

[15]  Weidong Fang,et al.  Alterations in the limbic/paralimbic cortices of Parkinson's disease patients with hyposmia under resting-state functional MRI by regional homogeneity and functional connectivity analysis. , 2015, Parkinsonism & related disorders.

[16]  Ninon Burgos,et al.  New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .

[17]  M. Gluck,et al.  Motor‐symptom laterality affects acquisition in Parkinson's disease: A cognitive and functional magnetic resonance imaging study , 2017, Movement disorders : official journal of the Movement Disorder Society.

[18]  A. Takeda,et al.  Olfactory dysfunction and dementia in Parkinson's disease. , 2014, Journal of Parkinson's disease.

[19]  R. Doty,et al.  Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[20]  H. Reichmann,et al.  Olfactory fMRI in Patients with Parkinson's Disease , 2010, Front. Integr. Neurosci..

[21]  D. Bilecen,et al.  Functional imaging of the cerebral olfactory system in patients with Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[22]  A. Petrie,et al.  Regional differences in the severity of Lewy body pathology across the olfactory cortex , 2009, Neuroscience Letters.

[23]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[24]  N. Sobel,et al.  An odor is not worth a thousand words: from multidimensional odors to unidimensional odor objects. , 2013, Annual review of psychology.

[25]  L. Forsgren,et al.  Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease. , 2017, Parkinsonism & related disorders.

[26]  G. Stebbins,et al.  Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations. , 2014, Brain : a journal of neurology.

[27]  C. Caltagirone,et al.  Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic Form , 2016, PloS one.

[28]  J. Dukart,et al.  Age Correction in Dementia – Matching to a Healthy Brain , 2011, PloS one.

[29]  L. Timmermann,et al.  A systematic review on the applications of resting-state fMRI in Parkinson's disease: Does dopamine replacement therapy play a role? , 2015, Cortex.

[30]  K. Alaerts,et al.  Functional connectivity alterations in the motor and fronto-parietal network relate to behavioral heterogeneity in Parkinson's disease. , 2016, Parkinsonism & related disorders.

[31]  Y. Itoyama,et al.  Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[32]  Deborah C Mash,et al.  Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. , 2006, Parkinsonism & related disorders.

[33]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[34]  M. T. Pellecchia,et al.  Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients. , 2013, Parkinsonism & related disorders.

[35]  J. Toledo,et al.  Olfactory impairment predicts cognitive decline in early Parkinson's disease. , 2016, Parkinsonism & related disorders.

[36]  T. Kobayakawa,et al.  Smell identification in Japanese Parkinson's disease patients: using the odor stick identification test for Japanese subjects. , 2008, Internal medicine.

[37]  S. Luo,et al.  Official Japanese Version of the International Parkinson and Movement Disorder Society–Unified Parkinson's Disease Rating Scale: Validation Against the Original English Version , 2014, Movement disorders clinical practice.

[38]  Saho Ayabe-Kanamura,et al.  Development of a smell identification test using a novel stick-type odor presentation kit. , 2006, Chemical senses.

[39]  P. Pan,et al.  Voxel‐wise meta‐analysis of gray matter abnormalities in idiopathic Parkinson’s disease , 2012, European journal of neurology.

[40]  B. Gulyás,et al.  Olfactory Functions Are Mediated by Parallel and Hierarchical Processing , 2000, Neuron.

[41]  Thomas E. Nichols,et al.  Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.

[42]  Peter J Gianaros,et al.  Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study , 2015, The Lancet Neurology.

[43]  Hiroshi Fukuda,et al.  Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. , 2012, Brain : a journal of neurology.

[44]  M. Esiri,et al.  Alpha‐synuclein pathology in the olfactory pathways of dementia patients , 2007, Journal of anatomy.

[45]  C. Caltagirone,et al.  Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients. , 2015, Parkinsonism & related disorders.

[46]  O. Schillaci,et al.  Cortical activity during olfactory stimulation in multiple chemical sensitivity: a 18F-FDG PET/CT study , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  R. Albin,et al.  Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease , 2010, Brain : a journal of neurology.

[48]  D. Ffytche,et al.  The psychosis spectrum in Parkinson disease , 2017, Nature Reviews Neurology.